GB Meka
Stocks to watch

UHS

Compare

UNIVERSAL HEALTH SERVICES-B · Healthcare

$174.66
▼ 0.6%Close 2026-09-30

Live intraday price

Compare with our price levels

T2188.97
T1183.91
E1165.57
E3146.90
SL140.92

Close 2026-09-30: $174.66 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▼ Leaning negative

Not in the buy zone yet — needs to drop 5.2% · 1 whale recently bought

1 month
▲ 2.7%
3 months
▲ 16.1%
1 year
▼ 12.8%
Analyst target
$194.35 +11.3%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$165.57 -5.2%
E2$158.59 -9.2%
E3$146.90 -15.9%
Targets
T1$183.91 5.3%
T2$188.97 8.2%
T3$198.48 13.6%
Stop-loss
SL$140.92 -19.3%
Whale cost ~$178.88 2.4%

Risk : reward 1 : 2.0Moves ~$5.98 a day

⚖️ Positives and risks

✓ Positives (2)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
! Risks (4)
  • ●เซียนขายออก/ลดสัดส่วน 1 ราย: Joel Greenblatt (ลด)
  • ●แนวโน้มระยะยาวเป็นขาลง (ใต้ MA200 และ MA200 ชี้ลง)
  • ●MACD เพิ่งตัดลง (โมเมนตัมอ่อนลง)
  • ●อ่อนแอกว่าตลาด (S&P 500) -21% ใน 6 เดือน

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

SUSSMAN ELLIOT J MD MBA · Director

2026-03-13 · 356 shares @ $193.37

$68,841
Sell

SUSSMAN ELLIOT J MD MBA · Director

2026-03-11 · 318 shares @ $186.35

$59,258
Sell

Nimetz Warren J. · Director

2025-11-11 · 3,675 shares @ $223.28

$820,542
Sell

Nimetz Warren J. · Director

2025-11-11 · 142 shares @ $223.96

$31,802
Sell

SUSSMAN ELLIOT J MD MBA · Director

2025-10-29 · 965 shares @ $225.70

$217,799

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$10.5B
Next earnings2026-10-26
P/E (price to earnings)7.5
Forward P/E (on expected earnings)7.5
Revenue growth (YoY)+8.3%
Earnings growth (YoY)+10.1%
Net profit margin+8.4%
ROE+20.9%
Debt to equity (D/E)69%
Dividend yield0.45%
Analyst targets (high / low)$290.00 / $166.00
Number of analysts17
Trend and technical indicators
Trend short / mid / longSideways → · Uptrend ↗ · Downtrend ↘
RSI50
MA50 / MA200$171.49 / $180.88
Distance from MA200-3.4%
MACDJust crossed down
1-year high / low$245.26 / $139.92
vs. S&P 500 (6 months)-20.9%
Volume vs. average0.16×